This is the authors' abstract. We don't add key points for this paper.
The pleuromutilin derivative 14‐deoxy‐14‐[(2‐diethylaminoethyl)‐mercaptoacetoxy]‐mutilin HCl interferes strongly with cell‐free poly(U)‐directed polyphenylalanine synthesis in an extract from Escherichia coli (supernatant obtained by centrifugation at 30000 × g ). The compound is unable to inhibit the assembly of initiation complexes and does not significantly influence Phe‐tRNA attachment to the ribosomal A‐site catalyzed by elongation factor T. It does, however, reduce the puromycin release of formylmethionine from initiator tRNA bound to the P‐site, indicating that either the peptidyl transferase is affected or the binding of puromycin is abolished by this antibiotic. The influence of this agent on protein synthesis performed by E. coli polysomes is less pronounced than the inhibition of polyphenylalanine synthesis. The opposite effect has been reported for chloramphenicol. This mirror‐image‐like behaviour seems to suggest that both antibotics are related in their mode of action. The formation of the dipeptide fMet‐Ala coded for by R‐17 phage RNA is also impeded by the pleuromutilin derivative. The binding of Ala‐tRNA to the A‐site is affected in this reaction. Since attachment of Phe‐tRNA to ribosomes with an empty P‐site (dependent on elongation factor T) is not hindered, the inhibition of the tRNA binding to initiation complexes seems to indicate that the antibotic requires an occupied P‐site in order to prevent binding of aminoacyl‐tRNA to the A‐site.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hodgin et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: